Evidence map›Paper›PMID 40416198›Full record

ArticleCureus2025

High-Frequency Ultrasound Evaluation of the Nail Unit: Essential Insights for Clinicians.

Claudia Gonzalez, Lauren Valdivia-Muñoz

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Claudia GonzalezRadiology, Highly Specialized Ultrasound Center, Bogota, COL.
Lauren Valdivia-MuñozDermatology, Universidad Libre, Cali, COL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHigh-frequency ultrasound (HFUS) has become increasingly prevalent in dermatological clinical settings over the past decade. However, understanding its appropriate indications and significant utility in onychology is not fully exploited. Based on a clinical self-assessment, the study aimed to provide fundamental recommendations regarding the applications, indications, and limitations of HFUS in nail disorders.

methodsA clinical practice assessment survey, comprising 15-item multiple-choice questions focused on nail unit ultrasound, was distributed online to clinicians' members of the Colombian Network of Research and Treatment for Nail Disorders (RITU), during the first quarter of 2024. Participation was voluntary and anonymous; no financial compensation was offered. Aggregated responses were analyzed confidentially.

resultsAround 44 clinicians (86.4% dermatologists and 13.6% radiologists) participated in the study. While most acknowledged the value of HFUS in evaluating nail disorders, knowledge gaps were evident, particularly concerning optimal settings and proficiency maintenance. Despite the widespread use of HFUS, a gap in expertise was observed concerning its application in specific nail pathologies. Although HFUS was the preferred modality for many nail conditions, some concerns about its reliability suggest the need for further training to ensure confident and effective utilization.

conclusionThis study revealed significant knowledge gaps among clinicians regarding the appropriate application of dermatologic ultrasound and other imaging modalities in the evaluation of nail disorders. The findings emphasize the value and specific indications for HFUS in assessing nail pathology, highlighting the need for enhanced training and education in this specialized area.

Indexed as

dermatologic ultrasoundhigh-frecuency ultrasoundnail disordersonychologyultrasound

Identifiers

PMID40416198
PMCPMC12101875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.